<DOC>
	<DOCNO>NCT02336750</DOCNO>
	<brief_summary>Comparing Dexamethasone , Aprepitant Mirtazapine With Dexamethasone Aprepitant Delayed Emesis Control Appetite Improvement</brief_summary>
	<brief_title>Adding Mirtazapine Dexamethasone Aprepitant Delayed Emesis</brief_title>
	<detailed_description>A Phase III Trial Comparing Efficacy Safety Dexamethasone , Aprepitant Mirtazapine With Dexamethasone Aprepitant Delayed Emesis Control Appetite Improvement</detailed_description>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Mianserin</mesh_term>
	<criteria>1 . Patients delayed emesis receive AC regimen regimens include cisplatin , subsequently accept chemotherapy regimens 2 . Karnofsky Performance Status ≥60 . 3 . Life expectancy 3 month . 4 . Hemoglobin ≥ 90 g/L ( No blood transfusion within 14 day ) , Absolute Neutrophil Count ≥ 1.5×10^9/L , Platelet Count ≥ 75×10^9/L , Serum Bilirubin ≤ 1.5×ULN , ALT AST ≤ 3.0×ULN ( without liver metastasis ) , ALT AST ≤ 5.0×ULN ( liver metastasis ) , Serum Creatinine ≤ 1×ULN , Endogenous Creatinine Clearance＞60ml/min 5 . Be able read , understand complete questionnaire diary , include FLIE Food Diary . Note : Must able understand write Chinese . 6 . Be able understand study procedure sign inform consent . 7 . Meet one following contraception : For fertile women： 1 . Urine pregnancy test screen negative . If urine pregnancy test positive , patient could enrol serum pregnancy test negative . 2 . They agree abstinence use double barrier method contraception research , within least 14 day enrol one month last dose study medicine . 3 . If take oral contraceptive , patient agree add barrier method contraception research , within least 14 day enrol one month last dose study medicine . Unfertility define anyone following : 1 . Natural menopausal ( natural menopausal ≥6 month serum FSH Postmenopausal range , natural menopausal ≥12 month age ＞45 ) 2 . Bilateral tubal ligation 3 . 6 week bilateral oophorectomy ( without hysterectomy ) 1 . Treatment study medicine within 4 week enrollment unrecovered toxicity . 2 . Women reproductive age ( include gestation period , lactation , desire pregnancy , oral contraceptive ) 3 . Severe visceral disease : history myocardial infarction serious epilepsy need medicine . 4 . Mental disability emotional mental disorder . 5 . Another malignancy within 5 year ( except cure basal cell carcinoma skin cervical carcinoma ) . 6 . Uncontrolled disease , active infection ( pneumonia ) , diabetic ketoacidosis , gastrointestinal obstruction . And case would cause bias make patient expose unnecessary risk . 7 . Receiving dose systemic glucocorticoid treatment , local inhale corticosteroid allow . 8 . Benzodiazepines opioids treatment within 48 hour first day study , except single daily take triazolam , temazepam midazolam . ) Benzodiazepines opioids give 48 hour longer first day study allow patient continue medication . 9 . Having vomit , retch nausea within 24 hour cisplatin treatment first day study . 10 . Patient receive abdominal pelvic radiation week 6 day initiation study . 11 . Prior aprepitant treatment hypersensitivity history component study drug . 12 . Can swallow capsule . 13 . Not eligible study base investigator . 14 . Patients receive strong inducer CYP3A4 , carbamazepine , dipheninum , phenobarbitone , etc..</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>